Physician profile
Edward Machen
NPI 1255060232
$4,552.93
in general payments reported to CMS, 2019-2025
21 companies · $1,658 in 2025
The $1,658 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $144 · 2023: $1,247 · 2024: $1,504 · 2025: $1,658.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,408.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $897.96 | 2023-2025 | Barrigel, Urolift |
| Boston Scientific Corporation | $860.27 | 2022-2025 | Ams 700, Xpeeda Dsl Fiber, Solyx Sis System |
| Coloplast Corp | $738.62 | 2023-2025 | Titan, Isiris Astent Removal Device |
| Olympus America INC. | $335.02 | 2023-2025 | Itind System, Olympus, Bovie |
| Axonics, INC. | $250.57 | 2024 | Axonics, Bulkamid |
| Aroa Biosurgery Incorporated | $221.31 | 2023 | |
| Procept Biorobotics Corporation | $195.94 | 2025 | |
| Calyxo, INC. | $185.61 | 2025 | Cvac Aspiration System |
| Merck Sharp & Dohme LLC | $163.68 | 2023-2024 | Lynparza, Keytruda, Welireg |
| Janssen Scientific Affairs, LLC | $113.57 | 2024-2025 | Erleada |
| Cook Medical LLC | $112.62 | 2023 | Fiber Dust |
| Alnylam Pharmaceuticals INC. | $109.79 | 2024 | Oxlumo |
| Endo Pharmaceuticals INC. | $108.80 | 2023 | Xiaflex |
| Urogen Pharma, INC. | $45.24 | 2025 | |
| Blue Earth Diagnostics | $41.63 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $36.32 | 2024 | Irrisept |
| Abbvie INC. | $30.80 | 2025 | |
| Becton, Dickinson and Company | $30.72 | 2023 | Bard Urinary Drainage Bag |
| Ambu INC. | $29.67 | 2022 | |
| Angiodynamics, INC. | $23.41 | 2025 | Nanoknife |
| Astrazeneca Pharmaceuticals LP | $21.38 | 2023 | Lynparza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Machen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.